Nine BC health researchers have been funded in MSFHR’s third Innovation to Commercialization (I2C) competition. Each will receive funding to advance their medical treatments, diagnostic tools and assistive technologies towards practical application to improve health outcomes and enrich the health innovation ecosystem in BC.
I2C Program is designed to help BC health researchers advance their discoveries or inventions towards use in patient populations to improve health outcomes, benefit society, and enrich the health innovation ecosystem in BC. These researchers and their research programs help grow BC’s talent pool and contribute to a strong, sustainable knowledge economy. The nine 2019 I2C award recipients, working in Kelowna, Victoria and Vancouver, are advancing health innovations that range from new nanomedicines for type 2 diabetes; developing a safe and effective analgesic for chronic pain relief, and a smart multifunctional wound dressing for continuous monitoring and treatment of chronic injuries.